ArticleBriefings in bioinformatics2025
A comprehensive benchmarking of the AlphaFold3 for predicting biomacromolecules and their interactions.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Interpreting human genetic variation at atomic resolution.Nature genetics · 2026Review
- Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review.International journal of molecular sciences · 2026Review
- Mechanism and Component Study of Scorpion Peptides Regulation of Macrophage Polarization in Diabetic Wounds.Biomedicines · 2026Article
- HighFold4: extending AlphaFold3 to accurate cyclic peptide conformation prediction via custom chemical connectivity.Briefings in bioinformatics · 2026Article
- Convergence of cryo-electron microscopy and artificial intelligence in integrative structural biology: A critical review of advances, synergies, and implications for molecular biophysics and drug discovery.Journal of microscopy · 2026Review
- A simple probabilistic AlphaFold interaction score.Protein science : a publication of the Protein Society · 2026Article
- Limits of deep-learning-based RNA prediction methods.Nucleic acids research · 2026Article
- Geometric Deep Learning-Based Drug Design Models for Small-Molecule Drug Discovery.Molecular informatics · 2026Review
- PeptiVerse: A unified platform for therapeutic peptide property prediction.Nature communications · 2026Article
- A historical journey of metabolite-protein interaction discovery: from data harmonization to AI-driven prediction.Briefings in bioinformatics · 2026Review
- Targeting the Undruggable: Deep Learning-Driven Design of Peptide Therapeutics in Cancer.Pharmaceuticals (Basel, Switzerland) · 2026Review
- pIgR Stem Zone-Targeted Nanobodies as Apical-to-Basolateral Carriers for Inhaled Biologic Delivery Across Mucosal Barriers.Antibodies (Basel, Switzerland) · 2026Article
- Navigating the uncharted: AI-driven advances in protein structure, dynamics, interactions and ligand interactions for understudied families.BioData mining · 2026Review
- Integrating AlphaFold2, RoseTTAFold2, and HADDOCK to refine Protein-Protein Interaction (PPI) candidate selection: A case study with ZWINT.Biochemistry and biophysics reports · 2026Article
- Beyond the canonical: The role of post-transcriptional regulation in drug-target interaction prediction.PLoS computational biology · 2026Article
- HighRes_Builder: improved access and modeling of noncanonical residues for protein structure prediction.Briefings in bioinformatics · 2026Article
- Discovery of Novel Chemotype LRRK2 Inhibitors Through AlphaFold2-Generated Structure-Based Docking Screen.International journal of molecular sciences · 2026Article
- Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities.International journal of molecular sciences · 2026Review
- Confidence scoring for deep learning-predicted antibody-antigen complexes: AntiConf as a precision-driven metric.Briefings in bioinformatics · 2026Article
- PeptiVerse: A Unified Platform for Therapeutic Peptide Property Prediction.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Deep learning has significantly enhanced protein structure prediction, and AlphaFold2 marked a particular milestone among these methods for predicting protein monomer and complex structures. The AlphaFold3 represents a pivotal further advancement in biomolecular structure prediction, extending beyond proteins to model diverse assemblies. Despite attracting a huge number of users, there is still an absence of third-party benchmarks to fairly demonstrate the performance of the AlphaFold3. In this work, we benchmark AlphaFold3's performance across nine datasets, protein monomers, orphan proteins, alternative conformations, protein multimers, peptide-protein complexes, antigen-antibody complexes, RNA, RNA multimers, and protein-nucleic acid complexes, compared to AlphaFold2, AlphaFold-Multimer, and RoseTTAFoldNA, RhoFold+, NuFold and trRosettaRNA. For protein monomers, AlphaFold3 demonstrates improved local structural accuracy over AlphaFold2, though global accuracy gains are limited. In modeling general protein complexes, AlphaFold3 surpasses AlphaFold-Multimer in local structural prediction. For peptide-protein complexes, their performances are nearly indistinguishable, whereas on antigen-antibody complexes, AlphaFold3 is significantly superior. AlphaFold3 shows substantial superiority over RoseTTAFoldNA in protein-nucleic acid predictions, with significant gains in TM-score, local distance difference test scores, and interaction network fidelity scores, whereas for RNA multimers its advantage is limited to significant gains in local distance difference test scores. For RNA monomers, trRosettaRNA achieves higher global prediction accuracy. These results highlight AlphaFold3's ability to predict both structural detail and interactions, positioning it as a versatile tool for diverse biomolecular systems and suggesting promising applications in structural biology and molecular interaction research, while at the same time highlighting areas ripe for continuing improvements in performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.